F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
- Conditions
- Prostate AdenocarcinomaPSA Level Greater Than 0.2PSA Level Greater Than or Equal to TwoPSA ProgressionRecurrent Prostate Carcinoma
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2022-01-21
- Lead Sponsor
- Andrei Iagaru
- Registration Number
- NCT03501940
- Locations
- 🇺🇸
Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer
Phase 2
Completed
- Conditions
- Stage II Prostate AdenocarcinomaStage III Prostate AdenocarcinomaStage IV Prostate Adenocarcinoma
- Interventions
- Procedure: Computed TomographyOther: Laboratory Biomarker AnalysisProcedure: Positron Emission Tomography
- First Posted Date
- 2017-04-13
- Last Posted Date
- 2023-12-12
- Lead Sponsor
- Andrei Iagaru
- Target Recruit Count
- 44
- Registration Number
- NCT03113617
- Locations
- 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States
68Ga-PSMA-11 PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery
Phase 2
Completed
- Conditions
- Stage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
- Interventions
- Procedure: Magnetic resonance imaging (MRI)Procedure: Positron Emission Tomography (PET)
- First Posted Date
- 2016-02-09
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Andrei Iagaru
- Target Recruit Count
- 74
- Registration Number
- NCT02678351
- Locations
- 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States
68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Phase 2
Completed
- Conditions
- Recurrent Prostate CarcinomaProstate AdenocarcinomaPSA Failure
- Interventions
- Procedure: Computed Tomography (CT) scanProcedure: Positron Emission Tomography (PET)
- First Posted Date
- 2016-02-03
- Last Posted Date
- 2022-01-13
- Lead Sponsor
- Andrei Iagaru
- Target Recruit Count
- 61
- Registration Number
- NCT02673151
- Locations
- 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Adenocarcinoma
- Interventions
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2023-04-10
- Lead Sponsor
- Andrei Iagaru
- Target Recruit Count
- 122
- Registration Number
- NCT02624518
- Locations
- 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States
18F-FSPG PET/CT for Cancer Patients on Therapy
Phase 2
Completed
- Conditions
- HER2/Neu NegativeMetastatic Renal Cell CancerStage IIIC Breast CancerStage IV Breast CancerStage IV Renal Cell CancerTriple-Negative Breast CarcinomaStage IIIA Breast CancerStage IIIB Non-Small Cell Lung CancerEstrogen Receptor NegativeStage III Renal Cell Cancer
- Interventions
- First Posted Date
- 2015-11-06
- Last Posted Date
- 2019-01-03
- Lead Sponsor
- Andrei Iagaru
- Target Recruit Count
- 7
- Registration Number
- NCT02599194
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States
68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors
- Conditions
- Other Neuroendocrine TumorsCarcinoid TumorsIslet Cell (Pancreatic NET)
- First Posted Date
- 2013-11-11
- Last Posted Date
- 2017-08-23
- Lead Sponsor
- Andrei Iagaru
- Registration Number
- NCT01980732
- Locations
- 🇺🇸
Stanford University, School of Medicine, Stanford, California, United States
© Copyright 2025. All Rights Reserved by MedPath